<DOC>
	<DOCNO>NCT02371707</DOCNO>
	<brief_summary>This study aim establish bioequivalence two tablet formulation idalopirdine</brief_summary>
	<brief_title>Bioequivalence Study Idalopirdine Tablets 60 mg</brief_title>
	<detailed_description />
	<criteria>Healthy men woman ≥18 ≤55 year age body mass index ( BMI ) &gt; 18.5 &lt; 30 kg/m2 Pregnant lactate woman Other protocol define inclusion exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>